Kontaktujte nás | Jazyk: čeština English
dc.title | Controlled drug delivery device for cornea treatment and novel method for its testing | en |
dc.contributor.author | Urbánek, Pavel | |
dc.contributor.author | Šuly, Pavol | |
dc.contributor.author | Ševčík, Jakub | |
dc.contributor.author | Hanulíková, Barbora | |
dc.contributor.author | Kuřitka, Ivo | |
dc.contributor.author | Šopík, Tomáš | |
dc.contributor.author | Stodůlka, Pavel | |
dc.relation.ispartof | Pharmaceuticals | |
dc.identifier.issn | 1424-8247 Scopus Sources, Sherpa/RoMEO, JCR | |
dc.date.issued | 2023 | |
utb.relation.volume | 16 | |
utb.relation.issue | 4 | |
dc.type | article | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.identifier.doi | 10.3390/ph16040505 | |
dc.relation.uri | https://www.mdpi.com/1424-8247/16/4/505 | |
dc.subject | controlled drug release | en |
dc.subject | drug delivery device | en |
dc.subject | cornea treatment | en |
dc.description.abstract | A new solution for local anesthetic and antibiotic delivery after eye surgery is presented. A contact lens-shaped collagen drug carrier was created and loaded by Levofloxacin and Tetracaine with a riboflavin crosslinked surface layer, thus impeding diffusion. The crosslinking was confirmed by Raman spectroscopy, whereas the drug release was investigated using UV-Vis spectrometry. Due to the surface barrier, the drug gradually releases into the corneal tissue. To test the function of the carrier, a 3D printed device and a new test method for a controlled drug release, which mimics the geometry and physiological lacrimation rate of the human eye, were developed. The experimental setup with simple geometry revealed that the prepared drug delivery device can provide the prolonged release profile of the pseudo-first-order for up to 72 h. The efficiency of the drug delivery was further demonstrated using a dead porcine cornea as a drug recipient, without the need to use live animals for testing. Our drug delivery system significantly surpasses the efficiency of antibiotic and anesthetic eyedrops that would have to be applied approximately 30 times per hour to achieve the same dose as that delivered continuously by our device. | en |
utb.faculty | University Institute | |
dc.identifier.uri | http://hdl.handle.net/10563/1011521 | |
utb.identifier.obdid | 43884805 | |
utb.identifier.scopus | 2-s2.0-85154587356 | |
utb.identifier.wok | 000976992800001 | |
utb.identifier.pubmed | 37111260 | |
utb.source | j-scopus | |
dc.date.accessioned | 2023-05-24T13:10:16Z | |
dc.date.available | 2023-05-24T13:10:16Z | |
dc.description.sponsorship | Ministerstvo Školství, Mládeže a Tělovýchovy, MŠMT; Ministerstvo Průmyslu a Obchodu, MPO: RP/CPS/2022/007 | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.access | openAccess | |
utb.ou | Centre of Polymer Systems | |
utb.contributor.internalauthor | Urbánek, Pavel | |
utb.contributor.internalauthor | Šuly, Pavol | |
utb.contributor.internalauthor | Ševčík, Jakub | |
utb.contributor.internalauthor | Hanulíková, Barbora | |
utb.contributor.internalauthor | Kuřitka, Ivo | |
utb.contributor.internalauthor | Šopík, Tomáš | |
utb.fulltext.sponsorship | This article was supported by project FV40377 funded by the Ministry of Industry and Trade of the Czech Republic. J.Š. especially thanks to project DKRVO–RP/CPS/2022/007 provided by the Ministry of Education, Youth and Sports of the Czech Republic. | |
utb.wos.affiliation | [Urbanek, Pavel; Suly, Pavol; Sevcik, Jakub; Hanulikova, Barbora; Kuritka, Ivo; Sopik, Tomas] Tomas Bata Univ Zlin, Ctr Polymer Syst, Trida Tomase Bati 5678, Zlin 76001, Czech Republic; [Stodulka, Pavel] Gemini Eye Clin, U Gemini 360, Zlin 76001, Czech Republic | |
utb.scopus.affiliation | Centre of Polymer Systems, Tomas Bata University in Zlín, trida Tomase Bati 5678, Zlin, 76001, Czech Republic; Gemini Eye Clinic, U Gemini 360, Zlin, 76001, Czech Republic | |
utb.fulltext.projects | FV40377 | |
utb.fulltext.projects | DKRVO–RP/CPS/2022/007 |